Last month marked Women’s History Month, and in February there was International Day of Women and Girls in Science, too. But, ...

Oligonucleotide (oligo) therapies have been in development for decades. Recent advances in molecular design, chemistry, ...

The regulator has sent a complete response letter (CRL) to AbbVie for trenibotulinumtoxinE (TrenibotE), a follow-up to its ...

In addition to the three NPVs, the FDA also announced the approval of an IND submission for DemeRx, which is investigating ...

Clinical trial sponsors and contract research organisations (CROs) are expanding clinical trials internationally to access ...

Regeneron has become the first company to get US approval for a gene therapy for congenital hearing loss, after the FDA gave ...

The phase 3 LITESPARK-012 trial is testing triplet therapy with oral HIF-2 alpha inhibitor Welireg (belzutifan) given ...

In biotech, value is created at discrete moments – when data resolves uncertainty. Until then, risk remains. Every dollar ...

The Telethon Undiagnosed Diseases Programme (TUDP), run by the Naples-based biomedical charity Fondazione Telethon, has ...

Armed with new phase 3 data, Novo Nordisk has said it will file for approval of oral formulations of its GLP-1 agonist ...

The trio of positive studies means that AZ is in pole position to bring an anti-IL-33 drug to market for COPD, after some ...

Berkeley, California biotech Ray Therapeutics, a specialist in the development of optogenetic therapies for eye disorders, ...